Cambria Investment Management, L.P. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cambria Investment Management, L.P. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$79,000
-73.5%
43,890
+23.5%
0.03%
-73.6%
Q2 2020$298,000
+70.3%
35,530
+6.2%
0.11%
+69.2%
Q1 2020$175,000
+9.4%
33,440
+14.3%
0.06%
+54.8%
Q4 2019$160,000
+73.9%
29,260
+55.6%
0.04%
+200.0%
Q3 2019$92,00018,8100.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders